Serum Hepatitis a Antibody Positivity Correlates with Higher Pancreas Cancer Mortality in Adults: Implications for Hepatitis Vaccination in High Risk Areas

  • Published : 2013.05.30


Background: This study used pre-hepatitis A vaccination era data in U.S. to study the relationship between serum hepatitis A antibody positivity with pancreas cancer mortality in adults. Patients and Methods: Public use National Health and Nutrition Examination Survey (NHANES III) data were employed. NHANES III uses complex probabilistic methods to sample nationally representative samples. Household adult laboratory and mortality data were merged. Sample persons who were available to be examined in the Mobile Examination Center (MEC) were included in this study. All results were obtained by using specialized survey software taking into account the primary sampling unit and stratification variables and the weights assigned to the sample persons examined in the MEC. Thus they are representative of the U.S. population. Results: The mean risk (95%CI) of death in the study population for pancreas cancer was 0.0014 (-0.000069 -.0029); their mean age (95%CI) at the mobile examination center (MXPAXTMR) was 473.43 (463.85-482.10); the follow up in months from their medical examination (permth_exm) was 170.12 (164.17-176.07). The odds ratios (S.E.) of the statistically significant univariables were: age, 1.007 (1.005-1.009); serum anti-hepatitis antibody status, 0.038 (0.004-0.376); and drinking hard liquor, 1.014 (1.004-1.023). The coefficients (S.E.) of the statistically significant variables after multivariate analysis were 0.006 (0.002-0.010) for age and -2.528 (-4.945--0.111) for serum anti-hepatitis A antibody negativity (using serum anti-hepatitis A antibody positivity as a reference). Conclusion: Serum hepatitis A antibody positivity correlates with higher pancreas cancer mortality in adults.


  1. Bell B P, Kruszon-Moran D, Shapiro C N, et al (2005). Hepatitis A virus infection in the United States: serologic results from the third national health and nutrition examination survey. Vaccine, 23, 5798-806.
  2. Chang S L, Harshman L C, Presti J C Jr (2010). Impact of common medications on serum total prostate-specific antigen levels: analysis of the national health and nutrition Examination Survey. J Clin Oncol, 28, 3951-7.
  3. Cohen S B (1997). An Evaluation of Alternative PC-Based Packages for the Analysis of Complex Survey Data. The American Statistician, 51, 285-92.
  4. Dowd J B, Zajacova A, and Aiello A (2009). Early origins of health disparities: burden of infection, health, and socioeconomic status in U.S. children. Soc Sci Med, 68, 699-707.
  5. Ezzati-Rice T M, and Murphy R S (1995). Issues associated with the design of a national probability sample for human exposure assessment. Environ Hlth Perspect, 103, 55-9.
  6. Gapstur S M, Jacobs E J, Deka A, McCullough M L, Patel A V, and Thun M J (2011). Association of alcohol intake with pancreatic cancer mortality in never smokers. Arch Intern Med, 171, 444-51.
  7. Graubard B I, and Korn E L (1999). Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst, 91, 1005-16.
  8. Halicioglu O, Akman S A, Tatar B, Atesli R, and Kose S (2012). Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey. Travel Med Infect Dis, 10, 43-7.
  9. Hsieh C F, Liu C K, Fang T J, et al (2009). Previous hepatitis a virus infection is related to slower psychomotor speed in elderly adults. J Gerontol A Biol Sci Med Sci, 64, 1090-6.
  10. Jewell N P (2004). Statistics for Epidemiology (Boca Raton, Florida, Champman & Hall/CRC).
  11. Klevens R M, Kruszon-Moran D, Wasley A, et al (2011). Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the national health and nutrition examination survey. Public Health Rep, 126, 522-32.
  12. Lemeshow S, and Cook E D (1999). Practical considerations in the analysis of complex sample survey data. Rev Epidemiol Sante Publique, 47, 479-87.
  13. McQuillan G M, Kruszon-Moran D, Kottiri B J et al (2004). Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994. Am J Pub Hlth, 94, 1952-8.
  14. Menke A, Guallar E, Rohrmann S, et al (2010). Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol, 171, 583-592.
  15. Schooling C M, Jones H E, and Leung G M (2011). Lifecourse infectious origins of sexual inequalities in central adiposity. Int J Epidemiol, 40, 1556-64.
  16. Velasco-Mondragon E, Lindong I, and Kamangar F (2012). Determinants of anti-hepatitis a antibody seroprevalence in 2- to 19-year-olds in the USA using NHANES 2007-2008. Epidemiol Infect, 140, 417-25.
  17. Verma R, and Khanna P (2012). Hepatitis a vaccine should receive priority in national immunization schedule in India. Hum Vaccin Immunother, 8, 1132-4.
  18. Younossi Z M, and Stepanova M (2011). Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population. Hepatology 54, 1167-78.